Dr Dan Strange is a biomedical engineer at TTP, an independent technology company that invents, designs and develops automation, tools and technologies for cell therapy manufacturing, working in close partnership with clients from across this industry. Dan has as worked across the ‘arm to arm spectrum’, on devices for tissue collection, cell selection, expansion and delivery, and with leading pharmaceutical companies to develop and commercialise devices for complex medicines used by hundreds of thousands of patients per year with high reliability rates. He is passionate about designing technology for a future where cell therapies have similar reach.